Pectins isolated from
Introduction
The number of people in the world with diabetes mellitus (diabetes) has quadrupled since 1980. In 2012, the disease directly caused 1.5 million deaths worldwide. 1 Diabetes is actually a spectrum of chronic metabolic disorders characterized by hyperglycemia. 2 There are two major categories: type 1 diabetes, which is classified as an autoimmune disease with insulin deficiency; and type 2 diabetes, which is mainly caused by insulin ineffectiveness. 3 Medications that can continuously control blood glucose levels and other diabetic symptoms are still being sought.
Asian ginseng (ginseng), derived from the rhizome and root of Panax ginseng C.A. Meyer, has promise as an antidiabetic therapeutic. According a Both the authors contributed equally to this work.
to Bencao Gangmu (a compendium of materia medica written in the 16th century A.D.), ginseng has long been used to treat hyperphagia (excessive food intake) and weight loss, which are two classic symptoms of diabetes in modern medicine. 4 Ginseng pectins have been extensively studied since the mid-20th century. 5 It has been revealed that ginseng pectins possess potent hypoglycemic, 6 antioxidative, 7 immunomodulative, 8 and anticancer 9 activities, alleviating diabetic conditions and complications. Therefore, ginseng pectins have potential to be developed as antidiabetic medicines.
Pectin is a family of galacturonic acid (GalA)-rich polysaccharides that are mostly found in primary cell walls. 10 Three types of ginseng pectins have been isolated and investigated: homogalacturonan (HG), rhamnogalacturonan (RG-I), and rhamnogalacturonan II (RG-II) ( with partly methyl-esterified carboxyl groups. 11 RG-I has a backbone of disaccharides composed of ␣-d-GalpA and rhamnosyl (Rha); the most frequent side chains are arabinogalactans (AG), linear or branched, containing ␣-l-arabinofuranosyl (Araf) and galactopyranosyl (Galp). RG-II has a polyGalA backbone 12 decorated with rarely observed monosaccharides, such as apiose (Api), and special glycosyl linkages, including 3,4-linked fucose (Fuc) and 2-linked glucuronic acid (GlcA). It is often found as a dimer with a borate diester crosslink. 13 Bioactivities of polymers vary greatly according to their structures. For competent management of and therapy for diabetes with few adverse effects, structurally tailored pectins are anticipated. 14 Yet, current studies of ginseng pectins have not been systematized. Researchers from different laboratories applied respective methods of sample preparation. The resulting pectins were investigated in various cell and animal models. The therapeutic efficacies of such pectins can hardly be compared because they have distinct structures in the first place. Sorting out and analyzing literature regarding ginseng pectins is necessary for in-depth study of the carbohydrates.
Here, we summarize how ginseng pectin structures can be affected by preparation methods and how the different forms thus produced act against multiple targets in treating diabetes. Preparationstructure and structure-function relationships are defined, as far as possible, based on existing information. We propose strategies for using this knowledge to tailor ginseng pectins specifically for treating diabetes.
Preparation-related structural diversity of ginseng pectins

Sample collection and extraction
Growing area and botanical parts determine pectin content and properties, even before the samples enter a laboratory. Purified polysaccharides of ginseng collected from Korea, China, and Japan were compared by nuclear magnetic resonance (NMR) spectroscopy and sugar content analysis, and the results greatly varied among the samples. [15] [16] [17] [18] [19] It has been shown that ginseng leaves contained more acidic polysaccharides than the roots and that the ginseng pectins isolated from the leaves have different pharmacological efficacies from that derived from the roots. 20 Most of the RG-II ginseng pectins used in experiments have come from the leaves instead of other plant parts. 21 In comparison, rootderived ginseng pectins comprise multiple domains, including HG, RG-I, and AG.
A series of studies have been carried out in Yifa Zhou's laboratory examining how extraction methods affect the structure and consequent pharmacological activities of ginseng pectins. Hot water, ␣-amylase, and ethylenediaminetetraacetic acid (EDTA) were used to extract ginseng root, yielding carbohydrates with diverse characteristics, correspondingly named WGP, 22 WGPE, 23 and EGP. 24 Lymphocyte proliferation potency in vivo was determined in decreasing sequence as EGP > WGPE > WGP. Structures of the pectic fractions
have not yet been elucidated in detail. The studies jointly demonstrated that EDTA and ␣-amylase, compared with hot water, can extract some novel and active polysaccharides from ginseng.
Chemical modification: acid hydrolysis and heat processing
The degree of acid hydrolysis affects the structures of highly branched carbohydrates. For example, when being hydrolyzed, the molecular weight of an RG-Itype pectin isolated from ginseng root was observed to steadily decrease; the Ara residues dramatically reduced; while Rha and GalA were not hydrolyzed. 25 The results indicated that the RG-I backbone consisting of Rha and GalA remained intact during hydrolysis, while the AG side chains were gradually cleaved. Ara was located near the surface of the pectin molecule, while Gal resided closer to its core. The conclusion is consistent with findings from work on other herbal pectins showing that the acidaffected structural variations of pectins are mainly related to their RG-I contents and integrity. 26 It has been traditionally agreed that steaming helps to improve the therapeutic potency of ginseng. There are three common ginseng preparations on the market, referring to the medicine not steamed at all (white ginseng); steamed for a short period of time (red ginseng), or steamed for a long period of time (black ginseng). 27 Corresponding to the traditional use, heat processing has been confirmed to increase acidic polysaccharides 27 and to enhance antihyperglycemic and antioxidant activities of ginseng pectins. 28 The pharmacological changes can be attributed to the temperature-induced modifications in the structures of the extract. Steaming affects pectic structures by slightly increasing molecular weight and reducing Gal content and by un-esterifying GalA residues. Moreover, polysaccharide domains respond differently to the steaming process: HG is the most sensitive to high temperatures, AG less sensitive, and neutral carbohydrates insensitive to the treatment. 9 Isolation and purification Multiple approaches have been developed to isolate pectins from other substances (Table 1) : (1) adding ethanol at high concentrations (80-95%) to remove small molecules; (2) applying the Sevag method to remove proteins; and (3) using cetrimonium bromide (CTAB) and boric acid to eliminate DNA from the samples. It has been widely confirmed that the three methods are effective in purifying polysaccharides; however, the procedures involve physical and chemical disturbance to polysaccharides, which may affect the carbohydrate structural properties (e.g., polymerization degree, the types of sugar chain, and glucosidic linkage) to various extents. The influence of the above techniques to pectin structures needs to be further elucidated.
DEAE-Sepharose R and DEAE-Cellulose R are two representative ion-exchange column (IEC) types used to separate pectins per ionic interaction between the polar carbohydrates and the stationary phase. Increasing salt concentration in the elution buffer leads to displacement of the bound molecules with the lowest isoelectric points (pI). 29 Therefore, raising the concentration of the eluent (e.g., NaCl) releases pectin fractions with more uronic acid contents, especially GalA. 22, 30, 31 The more acidic pectins are often found to have more potent pharmacological effects. 30 In addition to IEC, size-exclusion chromatography (SEC) has usually been applied to separate pectins, mainly according to molecular weight. It has been observed that the content of uronic acid also affects the elution time.
22,28
Structure-associated antidiabetic activities of ginseng pectins
Hypoglycemic effects
Insulin secretion deficiency and insensitivity to insulin action can both result in glucose metabolism disorders and cause hyperglycemia. 32 In the 1980s, a group of polysaccharides named panaxans A-U was isolated from ginseng, with respective antihyperglycemic effects on normal mice and/or alloxaninduced diabetic mice. [15] [16] [17] [18] [19] However, not all of them were determined to be pectin molecules, and their hypoglycemic mechanisms were unclear. Two glucans, panaxans A and B, reduced blood glucose, probably by affecting hepatic enzymes 33 and by increasing insulin levels in blood plasma and increasing cellular sensitivity to insulin. 34 Since then, information from investigations of hypoglycemic activities of ginseng pectins has gradually accumulated ( Table 2) . One of the glucoselowering metabolic effects of ginseng pectins may be stimulating insulin secretion to promote glycogen synthesis. A pectin fraction of ginseng a No treatment; b no data available; c ethylenediaminetetraacetic acid; d ion-exchange chromatography (molar of NaCl as the eluent unless specified); e gel-filtration chromatography (elution order of fractions); f trifluoroacetic acid; g cetrimonium bromide;
h Concanavalin A-Sepharose affinity chromatography. For S-IA and S-IIA, the previous fraction was dissolved in 1/15 M phosphate buffer, pH 7.0. containing 0.15 M NaCl, 1 mM MgCl 2 , and 1 mM CaCl 2 , equilibrated and eluted with the same buffer; for GL-AIa, the previous fraction was dissolved in Tris-HCl buffer, pH 7.4, containing 1mM CaCl 2 , 1 mM MgCl 2 , 1mM MnCl 2 , and 0.15 M NaCl, equilibrated and eluted with the same buffer; for the three pectins, unbound fraction was used. polysaccharide, WGPA, has been proven effective in reducing fasting blood glucose in streptozocin (STZ)-induced diabetic mice. 35 The fraction significantly increased serum insulin and hepatic glycogen after 10 days of i.g. administration at 10 mg/kg to the animals. The hypoglycemic effects of ginseng pectins increased with the steaming temperature. 28 The heat processing transformed the esterified GalA into an un-esterified form, which may explain the increased potency in enhancing serum insulin level, reducing blood glucose, and regaining body weight in diabetic mice.
It has been claimed that ginseng glycopeptides (GGPs) exhibit different effects on glycogenesis, also reducing blood sugar levels, probably by inhibiting insulin resistance. 36 GGPs are a fraction of ginseng pectins containing 5.6% polypeptides that link with the polysaccharide moiety via covalent bonds. 6 Unlike insulin, which increases liver glycogen, GGPs significantly decrease hepatin but still reduce blood glucose in both normal and diabetic animals, including rats, mice, and rabbits. The hypoglycemic activity may be attributed to the enhancement of aerobic glycolysis through stimulating ␤-adrenoceptor and the activation of rate-limiting enzymes related to the tricarboxylic acid cycle. 36 The varied effect of GGP on liver glycogen level from other ginseng pectins might be due to its higher peptide percentage and characteristic molecular structure.
It has been found that ginseng pectins have other regulatory effects on blood glucose, including affecting the metabolism of purine, tryptophan, and fatty acids, and on energy production. 37 In a study of ginseng pectins on type 2 diabetic rats, a clear separation of urinary excretion profiles was observed between the disease model group and the pectin-treated group. Eight urinary biomarkers have been investigated before and after pectin consumption. A 2-week pectin administration evidently increased the urinary concentrations of inosine, serotonin, phenylpropionylglycine, dodecanedioic acid, and tetrahydrocortisol. Simultaneously, 1-methyladenine, 4-deoxyerythronic acid, and 5-hydroxyhexanoic acid were downregulated, indicating that ginseng pectins can regulate DNA metabolism, organic acid metabolism, and steroid hormone metabolism, all of which contribute to the complicated metabolic network of diabetes. 37 
Antioxidative effects
Insulin resistance and excess glucose in the internal environment are responsible for the increase of oxidative stress. 38 Apart from antihypoglycemic effects, WGPA showed notable antioxidative activities in both diabetic and normal mice (Table 2) . 7, 35 When used to treat STZ-induced diabetic mice, WGPA restored the levels of maleic dialdehyde (MDA) and superoxide dismutase (SOD) to the baseline. 35 In a forced-swim test, the immobility times were compared among normal mice orally administrated WGPA, ginseng neutral polysaccharides, or ginseng crude polysaccharides. 7 WGPA was demonstrated to be the most dose-efficient among the three fractions. Compared with the forced-swim rats treated with saline, rats that swam after taking WGPA were found to have increased SOD and glutathione peroxidase (GSH-Px) and reduced triglyceride (TG), creatine phosphokinase, lactic dehydrogenase, and MDA. The combined inhibition of oxidative stress by WGPA is probably due to protection of corpuscular membranes by preventing lipid oxidation via modifying several enzyme activities.
There is a positive correlation between steaming and the reducing ability of ginseng pectin. 28 Alloxan-induced diabetic mice orally treated with steamed ginseng pectins were found to have increased SOD, GSH-Px, vitamin C, and vitamin E and decreased MDA, in both serum and liver, compared with the model control group. The blood TG and total cholesterol levels were also downregulated in the pectin-treated animals. Un-esterified GalA induced by heat may contribute to prevent cellular damage by scavenging free radicals generated by reactive oxygen species.
Immunoregulatory effects
2 An HG-rich pectin extracted from Korean red ginseng, PGAP, can alleviate abnormalities in the immune system. It increased spleen weight and spleen cells in normal mice, mainly by increasing macrophages (Table 3) . 39, 40 Splenic hyperplasia can be either immunopotentiating or immunosuppressive when the pectins are administered in different dose ranges. With 10-30 mg/kg i.p. to mice, PGAP significantly promoted the generation of CD11b + cells and antibody-forming cell (AFC) response, 12 while, in the range of 100-300 mg/kg i.p. to mice, PGAP reduced the CD11b + cells and the AFC response. 13 It is believed that macrophage-derived nitric oxide (NO) was the mediator of the immunosuppression effect of RGAP at higher doses. 40, 41 Ginsan, an HG-rich pectin from Korean white ginseng, exerted immunomodulatory effects both in vitro and in vivo. When added to mice peritoneal macrophages (PMs), ginsan promoted mRNA expression of inducible nitric oxide synthase and a group of correlated cytokines produced by T helper 1 (T H 1) cells and macrophages, including interleukin (IL)-1␤, IL-6, IL-12, and tumor necrosis factor (TNF)-␣. 42 However, when injected into Staphylococcus aureus-infected mice, the HG pectins notably downregulated the cytokines. 8 The pharmacokinetics of pectins are different in cell and animal models, thus leading to varied immune responses. The decrease of proinflammatory cytokines in vivo was possibly caused by ginsan inhibiting Toll-like receptor (TLR) 2. Inhibition of TLR2 expression downregulates the activity of adaptor molecule MyD88, decreasing the expression of phosphoc-Jun N-terminal kinase 1/2, phos-p38 mitogeninduced protein kinase (MAPK), and nuclear factor B. In contrast to HG countering TLR2 in vivo, RG-II-rich pectins can function as TLR4 agonists in vitro. RG-II matured bone marrow-derived dendritic cells (BMDCs), activating MAPK families in a TLR-4-dependent manner. 43 Stimulated BMDCs boosted the generation of cytokines IL-1␤, IL-12, TNF-␣, and interferon-␥ and proliferation of CD8 + T cells. Besides, RG-II ginseng pectins interact with other targets, including the Fc receptor (FcR). In a mouse model, an RG-II pectin increased FcR expression to activate mononuclear phagocytosis, in turn enhancing immune complex clearance. 13 It also induced IL-6 production in mouse PMs. 44 AG side chains also exhibit significant immunoregulatory activities. WGPA-2-RG is a ginseng pectin fraction with a small RG-I backbone and long AG side chains. 22 Partial acid hydrolysis of WGPA-2-RG gave a new pectin named RG-6H-I, keeping the RG backbone but completely eliminating the AG branches. 25 Both pectin fragments enhanced phagocytic activities of mouse PMs, while only WGPA-2-RG increased lymphocyte proliferation and stimulated macrophage NO production. AG side chains and Ara residues are therefore essential for lymphocyte proliferation and NO secretion; however, they are less involved than RG-I in macrophage phagocytosis. More specifically, ␣-1,5-linked arabino-␤-3,6-branched galactan in AG can exert remarkable reticuloendothelial system (RES)-potentiating activities in vivo. 20, [45] [46] [47] [48] Activated RES triggers the complement system and intensifies immune response through the alternative pathway. 20 Moreover, the AG-rich pectin S-IIA has been found to induce mRNA expression and cytokine production of IL-8 in T H 1 cells and human blood monocytes, showing in vitro immunoregulatory activities. 47 
Tumoricidal effects
Owing to many overlapping pathogenic factors, diabetes (mainly type 2) is interlinked with cancer epidemiologically and biologically, increasing the risk of tumor generation and progression in the liver, pancreas, colorectum, stomach, lung, bladder, and breast. 49, 50 Convincing evidence indicates that cancer is a major complication of diabetes, and that some types of cancer (e.g., carcinoma of the pancreas) can destroy the insulin-producing cells and cause diabetes. 35 Therefore, therapeutic agents that fight against tumors can both manage diabetic complications and prevent diabetes (Table 3) .
HG-rich pectins have been shown to work synergistically with other cancer therapeutic agents. Paclitaxel is a tetracyclic diterpenoid that blocks mitosis, which is extensively applied in the treatment of various cancers, but with clinical toxicities. 51 When PGAP pectin and paclitaxel were administrated simultaneously to tumorbearing mice, tumor weight decreased and animal survival rate was notably elevated, compared with monotherapy with either agent. Moreover, PGAP restored spleen cell number and natural killer (NK) cell activity suppressed by paclitaxel. Therefore, PGAP allied with paclitaxel to enhance antitumor potencies and to reduce toxicities. 52 Recombinant-derived lymphokine interleukin-2 (rIL-2) is an immunotherapeutic agent with serious dose-limiting toxicity, which is seldom used alone. 53 Lymphokine-activated killer (LAK) cells are innately oriented to kill tumor cells. 53 In collaboration with rIL-2, pectin ginsan generated LAK cells from both NK and T cells through endogenously produced cytokines, demonstrating effectiveness in the immunotherapy of cancer. 54 The tumoricidal effects of PGAP and ginsan can be explained by their bioactive HG domains. A study on colon cancer cells demonstrated that HG-rich ginseng pectin potently inhibited tumor proliferation. 9 Steaming further enhanced the antitumor activities, probably by generating or enriching specific functional structures. Steamed HG pectins followed two dose-related routes of HT-29 inhibition: inducing cell cycle arrest at lower concentrations (0.6-1.25 mg/mL, 72 h) and inducing apoptosis at higher concentrations (1.25-2.5 mg/mL, 72 h). The pectins can induce apoptosis by activating the caspase-3-mediated apoptosis pathway. Other studies found that HG pectins enhanced the production of cytokines in T H 1 cells 54 and macrophages 42 and thus stimulated the production of cytotoxic cells.
Fibroblasts play a prominent role in the progression, growth, and spreading of cancers, via angiogenesis and injury response. 55 It has been discovered that HG and RG-I pectins can inhibit cell migration of fibroblasts, including L-929 and HT-1080 cells, and that GalA and Rha contents are positively correlated with the reduction of cell adhesion and cell spreading, two mediators of cell migration. 30 Such inhibition may be related to the galectin-3-binding property of ginseng pectins. Galectin-3 is a chimeric protein characterized by a conserved carbohydraterecognition domain with specific binding to ␤-galactosides. 56 The protein contributes to tumor progression; galectin-3 antagonists are promising cancer therapeutic agents. 57 To test whether ginseng pectins bind to galectin-3 to inhibit tumor growth, an RG-I pectin and its modified pectic fragments were assayed in vitro, showing that both RG-I backbones and AG side chains were important structural elements for anti-galactin-3 activity. 58 The RG-I backbones maintained structural confirmation to preserve the high binding affinity of the molecule. The ␤-1,4-galactan side chains are essential for the binding. Ara residues either promoted (terminal Ara) or impaired (␣-1,5-arabinan side chains) the affinity. The side chains cooperated; the activity of a galactan chain was proportional to the length of up to four Gal residues and remained unchanged thereafter.
The AG domain has also been shown to have apoptotic functions. PGP2a, an AG-rich ginseng pectin, arrested HGC-27 gastric tumor cells at G 2 /M phase and dose-dependently induced apoptosis, via both the mitochondrial-mediated intrinsic and death receptor-mediated extrinsic apoptotic pathways. 59 The pectin-induced apoptosis might be mediated by modulation of Twist and its downstream gene expression.
Well-defined pectin preparation is envisaged
Different treatments of pectins yield macromolecules with diverse structures (Table 1) . Preparation methods vary between laboratories, making interlaboratory comparison of polysaccharide fractions difficult. Several groups of scientists have been dedicated to ginseng pectin research for decades, each concentrating on different bioactive polymers. A group of Japanese researchers isolated and purified polysaccharides from ginseng root grown in Asian countries with diverse chemical and pharmacological properties. [15] [16] [17] [18] [19] Another Japanese team led by Haruki Yamada focused on ginseng leaf polysaccharides and has shown variation from those isolated from roots. 20, 44, 48, [60] [61] [62] Two South Korean research groups investigated pectin from Korean red 39, 40 and white 8, 54, 63 ginseng. A Chinese group from Jilin province has focused their work on GGPs, which are pharmacologically unique. 6, 36 Yifa Zhou and his colleagues fractioned a series of pectin fragments by different methods for further investigation. 22, 24, 25, 31, 64 Such a diversity of methods used in the preparation of ginseng pectins largely hinders its quality control and evaluation. An optimized treatment template remains to be defined with which researchers can obtain a standard or at least an authenticated range of the polymers. Key preparation procedures of ginseng pectins include (1) sample collection, (2) extraction, (3) purification, (4) chemical modification, and (5) isolation, all of which heavily affect the pectic chemical and pharmacological properties. During sample collection, selecting the appropriate origin of growth and botanical part of the herbal material is necessary. Extraction with long times, high temperature, large solvent volume, and multiple extraction steps favors high yield of polysaccharides. Different concentrations of extraction solvents are selected according to the target extract. Ethanol precipitation is usually applied after extraction in order to remove small molecules; the Sevag method is a common deproteinizing choice to purify the samples; CTAB and boric acid can be further used to eliminate DNAs from pectins. Steaming is an optional step to modify ginseng pectin structures, which may increase the acidity and alter biological efficacies of pectins. Ion-exchange chromatography and gel filtration chromatography are major techniques for isolating polysaccharides according to their charges and molecular weights, respectively.
To establish an entire preparation process for designated ginseng pectins, it is essential to optimize the parameters for each step in the above-mentioned treatment template (Fig. 2) . There is room for improvement of particular approaches. For example, the current column separation methods are tedious and lack accuracy; thus, a replacement for such long-time fractionation is sorely needed.
Toward multidimensional determination of pectin structure
At present, the criterion for judging whether a polysaccharide is homogeneous is whether it gives a single peak in ion-exchange or SEC. 22, 48, 59 The criterion is misleading in that the purity of a polysaccharide sample does not solely rely on charge or molecular weight. 65 Low purification and high heterogeneity of pectin structures hinders establishment of structure-function relationships. 66 Hence, when assessing the purity of a polysaccharide, consideration should also be given to factors other than the symmetric peak, such as the branching degree of the carbohydrates, as well as contents of other polymeric components, including nucleic acids and peptides.
Multiple polysaccharide structure-determination approaches have been developed, including monosaccharide composition, 30 gas chromatography mass spectrometry, 60 Fourier transform infrared spectroscopy, 65 66 However, more delicate structures are yet to be discovered. It is worth noting that not only the existence but also the distribution of the structural elements contribute to the overall properties of pectins.
In addition to the basic structural units, advanced constructions of polysaccharides also remain to be explored. Inter-and intramolecular interactions significantly affect the 3-D structure of polysaccharides. A future challenge lies in computer-assisted modulation of the 3-D edible macromolecules, calculating their binding affinities to receptors, and designing the optimal polysaccharides with healthpromoting potencies.
Pectin-target interactions in diabetes therapy
Polysaccharides rich in HG, RG-II, RG-I, and AG domains have structurally specific mechanisms to alleviate abnormalities in the metabolic system, consequently managing diabetes (Fig. 3) . Modification of GalA, the most abundant monosaccharide in pectins, will greatly alter the therapeutic potency of pectin. Un-esterified GalA plays an inevitable role in antihyperglycemic and antioxidative activities. Low pH and high temperature facilitate de-esterification and thereby promote pectin bioactivities. 25, 28 On RG-I backbones, unbranched GalA residues contribute to stimulate the immune system, while the branched ones, usually at O-2 or O-3, significantly suppress the anticomplementary activity of the pectin. 48 HG pectin has both antitumor and immunoregulatory functions. Mechanisms of HG pectin action against tumors may include (1) induction of cell cycle arrest and apoptosis; 9 (2) inhibition of cell migration and thus prevention of cancer generation and progression; 30 and (3) production of proinflammatory cytokines stimulating the generation of tumor-killing cytotoxic cells. 42 As for the immunoregulatory effects, HG comprises a linear chain of GalpA with a high degree of esterification that competes with lipopolysaccharides; thus, the carbohydrate moiety can block TLR2, preventing inflammatory cell activation. 67 The poly-GalA backbone of both HG and RG-II pectin enables their binding to TLR proteins with high affinity. However, unlike HG, which is a linear chain, RG-II possess unique monosaccharide composition, side chain decoration, and borate dimerization, making the moiety an agonist of TLR4 instead of blocking the protein. 43 Detailed mechanisms of specific pectin structures activating and inhibiting TLR await further study.
The RG-I backbone usually serves as a support for its side chains, which have bioactivities. The AG moiety can not only affect enzymes related to the apoptosis pathways, 59 but also modulate immune responses. 25 In particular, in AG chains, the occurrence of ␤-1,4-galactans, ␣-1,5-arabinans, and terminal Ara residues, as well as the length of the galactan chains, all have different effects on protein binding, potentially preventing cancer growth.
58 ␣-1,5-Linked arabino-␤-3,6-branched galactans have special contributions to complement activation. 20, [45] [46] [47] [48] AG chains are greatly diverse in pectins, and they frequently interact with other structural elements to aid in the overall therapeutic effect of carbohydrates, contributing to the overall carbohydrate therapeutic potency.
Because pectins are polymers with multiple functional structural units, their pharmacokinetics and signal transduction pathways are extremely complicated. Studies on cell models of ginseng pectins have provided valuable information on their potential in treating diabetes, yet the experimental results should be critically evaluated to avoid overinterpretation of phenomenological observations. Compared with in vitro tests, animal models and clinical studies can better reflect ginseng pectin performance in complex body systems. Since diabetes is derived from a group of metabolic disorders, the biomarkers chosen to characterize the model and treatment groups should be both practical and representative of the complicated environment. Moreover, when taken orally, the carbohydrates will interact with or be degraded by gut microbiota. 68 The resulting metabolites with possibly modified structures and bioactivities will then function as antidiabetic agents acting on different receptors. To further explore the structure-function relationship of ginseng pectin, it is essential to reveal the interplay between structurally defined samples and complicated and as yet unspecified targets. 
Conclusions
The exact structures of ginseng pectins purified from the herbal material are strongly dependent on preparation procedures, including sample collection, extraction, chemical modification, isolation, and purification. Single or combined domains of HG, RG-I, RG-II, and AG can be applied as antidiabetic agents owing to prominent effects of lowering blood glucose, reducing oxidative stress, alleviating immunological disorders, and inhibiting cancers. Both the backbones and side chains of the polysaccharides are essential pharmacologically. Domain-specific functions are associated with but not limited to monosaccharide composition, peptide content, degrees of esterification and methylation, and inter-and intrapectin linkages. Standardizing the pectin preparation process, disclosing detailed and advanced pectin structures, and involving complex models with targeting networks are among the key strategies to further elucidate the relationship between structural diversity and antidiabetic therapeutic potency of ginseng pectins. The present review systematizes the available information regarding preparationstructure and structure-function relationships of ginseng pectins with antidiabetic potential, shedding light on safer and more pertinent treatments for diabetes with efficacy-oriented modified polysaccharides.
